Researchers assessed the efficacy of optimized adalimumab therapy in a large series of patients with uveitis due to Behçet disease. Source: AAO
Due to inclement weather conditions, both the Malta and Troy office of Saratoga ophthalmology will be closed tomorrow, Monday December 2nd. Our offices will be open and staff available to help reschedule appointments on Tuesday. Stay safe everyone and don’t drive unless you absolutely need to.
This retrospective case series evaluated the effectiveness of the hedgehog pathway inhibitor vismodegib for advanced periocular basal cell carcinoma (BCC). Source: AAO
This study compared the efficacy of a fixed-dose netarsudil/latanoprost combination therapy versus individual monotherapies for open-angle glaucoma and ocular hypertension. Source: AAO
This cross-sectional study compared the diagnostic accuracy of a smartphone-based artificial intelligence system versus ophthalmologist judgement for retinopathy screening in patients with diabetes. Source: AAO
This week, Aerie Pharmaceuticals expands into the dry eye space, two ophthalmic drugs snag orphan drug designations and NEI researchers unveil an AI-based system to screen stem cell-derived retinal tissues. Source: AAO
The authors retrospectively examined the performance of recently revised diagnostic criteria for pseudotumor cerebri syndrome. Source: AAO
This study assessed whether short-term use of topical NSAIDs or steroid therapy affects the efficacy of selective laser trabeculoplasty (SLT). Source: AAO
A contact lens for slowing pediatric myopia progression has received the FDA’s approval, according to manufacturer CooperVision. Source: AAO
This phase 3 trial assessed the safety and efficacy of OTX-101, an aqueous nanomicellar formulation of cyclosporine 0.09% for dry eye disease. Source: AAO